Pro-Dex (FRA:PDXN) Marketable Securities: €0.85 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PDXN Pro-Dex Inc FRA:PDXN
63 GF Score
Price €57.50
GF Value €35.46
! 10 Warning Signs
View Full Analysis

What is Pro-Dex Marketable Securities?

Pro-Dex FRA:PDXN +0.88% 63 Marketable Securities is €0.85 Mil as of Mar. 2026. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €35.46. The stock has 10 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Pro-Dex's Marketable Securities for the quarter that ended in Mar. 2026 was €0.85 Mil.

Pro-Dex's annual Marketable Securities increased from Jun. 2023 (€1.05 Mil) to Jun. 2024 (€3.92 Mil) and increased from Jun. 2024 (€3.92 Mil) to Jun. 2025 (€5.84 Mil).

Pro-Dex  (FRA:PDXN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Pro-Dex Marketable Securities Related Terms

Pro-Dex Marketable Securities Historical Data

* Premium members only.

The historical data trend for Pro-Dex's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex Marketable Securities Chart

Pro-Dex Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 0.71 1.05 3.92 5.84

Pro-Dex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.01 5.84 8.55 0.74 0.85
FRA:PDXN
63GF Score
Pro-Dex Inc FRA:PDXN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro-Dex Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.85 Mil mean?
Pro-Dex (FRA:PDXN) has a Marketable Securities of €0.85 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pro-Dex and its competitors.
Is Pro-Dex's Marketable Securities too high?
Pro-Dex's current Marketable Securities is €0.85 Mil. Overall, Pro-Dex has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Marketable Securities compare to KRMD and EMBC?
Pro-Dex's Marketable Securities of €0.85 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Pro-Dex and its competitors. Pro-Dex's current Marketable Securities is €0.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Pro-Dex (FRA:PDXN) has a current Marketable Securities of €0.85 Mil. The stock's GF Value™ is €35.46, compared to a current price of €57.50 — trading 62.2% above its estimated fair value. The current Marketable Securities is €0.85 Mil. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Marketable Securities is €0.85 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro-Dex (FRA:PDXN) Overvalued in 2026?

Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued. The current stock price of €57.50 is trading 62.2% above its estimated GF Value™ of €35.46.

Key valuation signals for FRA:PDXN:

  • Marketable Securities: €0.85 Mil
  • GF Value™: €35.46 vs. price of €57.50 (62.2% above fair value)
  • GF Score™: 63/100 with 10 warning signs

No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro-Dex Business Description

Other Exchanges PDEX:USA
Address 2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score

Get the complete analysis for FRA:PDXN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.50
Price
€35.46
GF Value